Candel Therapeutics IncNASDAQ:CADL
- LAST PRICE4.4700
- TODAY'S CHANGE (%)-0.1800 (-3.8710%)
- Bid / Lots4.3200/ 10
- Ask / Lots4.7400/ 7
- Open / Previous Close4.6500 / 4.6500
- Day Range
- 52 Week Range
- Volume357,888
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CADL |
|---|---|---|
| 09:32 ET | 2957 | 4.7301 |
| 09:35 ET | 5801 | 4.57 |
| 09:37 ET | 1700 | 4.55 |
| 09:39 ET | 445 | 4.542 |
| 09:42 ET | 3791 | 4.55 |
| 09:44 ET | 11415 | 4.5498 |
| 09:46 ET | 2207 | 4.55 |
| 09:48 ET | 21742 | 4.55 |
| 09:50 ET | 10084 | 4.5401 |
| 09:51 ET | 2177 | 4.5425 |
| 09:53 ET | 2169 | 4.55 |
| 09:57 ET | 1160 | 4.55 |
| 10:00 ET | 4825 | 4.4851 |
| 10:02 ET | 2806 | 4.49 |
| 10:04 ET | 517 | 4.5 |
| 10:06 ET | 1588 | 4.486 |
| 10:09 ET | 5717 | 4.49 |
| 10:11 ET | 1697 | 4.51 |
| 10:13 ET | 5065 | 4.47 |
| 10:15 ET | 6451 | 4.4518 |
| 10:20 ET | 100 | 4.47 |
| 10:22 ET | 100 | 4.47 |
| 10:26 ET | 1536 | 4.45 |
| 10:29 ET | 125 | 4.4682 |
| 10:31 ET | 850 | 4.45 |
| 10:33 ET | 1303 | 4.45 |
| 10:36 ET | 800 | 4.454 |
| 10:38 ET | 2594 | 4.48 |
| 10:42 ET | 600 | 4.4886 |
| 10:44 ET | 200 | 4.47 |
| 10:45 ET | 2200 | 4.435 |
| 10:47 ET | 2044 | 4.45 |
| 10:51 ET | 950 | 4.45 |
| 10:56 ET | 942 | 4.43 |
| 10:58 ET | 4493 | 4.45 |
| 11:02 ET | 4100 | 4.52 |
| 11:03 ET | 3775 | 4.5145 |
| 11:05 ET | 305 | 4.54 |
| 11:07 ET | 649 | 4.53 |
| 11:09 ET | 100 | 4.55 |
| 11:14 ET | 500 | 4.525 |
| 11:16 ET | 260 | 4.515 |
| 11:20 ET | 5700 | 4.52 |
| 11:21 ET | 100 | 4.53 |
| 11:25 ET | 100 | 4.53 |
| 11:27 ET | 200 | 4.5225 |
| 11:34 ET | 200 | 4.53 |
| 11:38 ET | 100 | 4.515 |
| 11:41 ET | 3100 | 4.515 |
| 11:43 ET | 100 | 4.515 |
| 11:45 ET | 1100 | 4.515 |
| 11:48 ET | 934 | 4.5 |
| 11:50 ET | 1905 | 4.5 |
| 11:52 ET | 1000 | 4.51 |
| 11:54 ET | 1500 | 4.53 |
| 11:56 ET | 300 | 4.54 |
| 11:57 ET | 2428 | 4.58 |
| 11:59 ET | 500 | 4.55 |
| 12:01 ET | 100 | 4.53 |
| 12:03 ET | 130 | 4.52 |
| 12:06 ET | 800 | 4.56 |
| 12:10 ET | 979 | 4.545 |
| 12:12 ET | 1500 | 4.56 |
| 12:17 ET | 698 | 4.52 |
| 12:19 ET | 300 | 4.5003 |
| 12:24 ET | 1804 | 4.49 |
| 12:26 ET | 283 | 4.52 |
| 12:30 ET | 898 | 4.519 |
| 12:35 ET | 1300 | 4.53 |
| 12:37 ET | 1000 | 4.53 |
| 12:39 ET | 100 | 4.54 |
| 12:42 ET | 100 | 4.53 |
| 12:46 ET | 300 | 4.53 |
| 12:48 ET | 3600 | 4.53 |
| 12:51 ET | 600 | 4.51 |
| 12:53 ET | 300 | 4.505 |
| 12:55 ET | 1000 | 4.5 |
| 12:57 ET | 750 | 4.49 |
| 01:06 ET | 259 | 4.47 |
| 01:09 ET | 500 | 4.4843 |
| 01:11 ET | 100 | 4.49 |
| 01:13 ET | 1038 | 4.49 |
| 01:15 ET | 2000 | 4.48 |
| 01:18 ET | 5965 | 4.465 |
| 01:24 ET | 100 | 4.48 |
| 01:26 ET | 300 | 4.47 |
| 01:29 ET | 102 | 4.47 |
| 01:36 ET | 496 | 4.47 |
| 01:40 ET | 100 | 4.47 |
| 01:47 ET | 285 | 4.47 |
| 01:51 ET | 200 | 4.4794 |
| 01:58 ET | 764 | 4.47 |
| 02:05 ET | 200 | 4.44 |
| 02:12 ET | 146 | 4.4301 |
| 02:16 ET | 2002 | 4.44 |
| 02:20 ET | 200 | 4.44 |
| 02:23 ET | 1082 | 4.45 |
| 02:27 ET | 100 | 4.47 |
| 02:30 ET | 425 | 4.46 |
| 02:32 ET | 100 | 4.46 |
| 02:36 ET | 200 | 4.45 |
| 02:43 ET | 298 | 4.46 |
| 02:45 ET | 454 | 4.4785 |
| 02:50 ET | 200 | 4.47 |
| 02:54 ET | 400 | 4.47 |
| 02:56 ET | 2395 | 4.4401 |
| 03:01 ET | 437 | 4.46 |
| 03:03 ET | 33603 | 4.3 |
| 03:06 ET | 1587 | 4.34 |
| 03:08 ET | 2896 | 4.36 |
| 03:10 ET | 345 | 4.38 |
| 03:12 ET | 300 | 4.45 |
| 03:14 ET | 1316 | 4.42 |
| 03:15 ET | 300 | 4.43 |
| 03:17 ET | 125 | 4.41 |
| 03:19 ET | 175 | 4.405 |
| 03:24 ET | 1550 | 4.405 |
| 03:26 ET | 1750 | 4.41 |
| 03:28 ET | 1316 | 4.39 |
| 03:32 ET | 200 | 4.39 |
| 03:35 ET | 2508 | 4.37 |
| 03:37 ET | 100 | 4.39 |
| 03:39 ET | 958 | 4.4167 |
| 03:44 ET | 644 | 4.425 |
| 03:46 ET | 200 | 4.425 |
| 03:48 ET | 729 | 4.425 |
| 03:50 ET | 3090 | 4.425 |
| 03:51 ET | 1400 | 4.425 |
| 03:53 ET | 3379 | 4.43 |
| 03:55 ET | 5037 | 4.42 |
| 03:57 ET | 9409 | 4.42 |
| 04:00 ET | 52601 | 4.47 |
Nov 7, 2024
Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
Oct 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Candel Therapeutics Inc | 149.2M | -2.6x | --- |
Vigil Neuroscience Inc | 146.7M | -1.7x | --- |
Ventyx Biosciences Inc | 151.9M | -0.9x | --- |
Context Therapeutics Inc | 153.0M | -1.9x | --- |
Outlook Therapeutics Inc | 153.1M | -0.8x | --- |
Achieve Life Sciences Inc | 153.5M | -4.1x | --- |
Company Information
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Contact Information
- Headquarters
- 117 Kendrick Street,, Suite 450NEEDHAM, MA, United States 02494
- Phone
- 617-916-5445
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Manning
- President, Chief Executive Officer, Director
- Paul Tak
- Interim Chief Financial Officer
- Charles Schoch
- Chief Scientific Officer
- Francesca Barone
- Chief Medical Officer
- W. Garrett Nichols
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $149.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 32.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.94 |
EPS | $-1.70 |
Book Value | $0.44 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
